Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans (Q28205943)
Jump to navigation
Jump to search
scientific article (publication date: February 2002)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans |
scientific article (publication date: February 2002) |
Statements
Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans (English)
0 references
February 2002
0 references
28
0 references
1
0 references
53-66
0 references